2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$12.96-$0.005 (-0.04%)
Price as of Sep 11, 2026 7:30 PM EDT- $377.5MMarket Cap
- 56.52%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$12.96-$0.005 (-0.04%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.96 | ||
Change | +$0.26 (+2.05%) | ||
Open | $12.83 | ||
High | $13.04 | ||
Low | $12.59 | ||
Previous Close | $12.70 | ||
Volume | 289,137 | ||
30-Day Average Volume | 238,189 | ||
1-Week Change | -7.95% | ||
1-Month Change | -4.14% | ||
1-Year Change | 56.52% | ||
3-Year Change | 3.93% | ||
5-Year Change | -76.89% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $296.9M | ||
Market Cap | $377.5M | ||
Enterprise Value | $344.0M | ||
Period: QTR TTM FY | |||
Revenue | $14.4M | ||
Net Income | -$19.5M | ||
Free Cash Flow | -$10.0M | ||
EBIT | -$15.3M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $149.5M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 4 | ||
P/E | -19 | ||
PEG | 0 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue